Share-based Payment Arrangement, Expense of MACROGENICS INC from 31 Dec 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
MACROGENICS INC quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2011 to 30 Sep 2025.
  • MACROGENICS INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $3,548,000, a 41% decline year-over-year.
  • MACROGENICS INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $22,889,000, a 1.6% increase year-over-year.
  • MACROGENICS INC annual Share-based Payment Arrangement, Expense for 2024 was $29,439,000, a 60% increase from 2023.
  • MACROGENICS INC annual Share-based Payment Arrangement, Expense for 2023 was $18,373,000, a 10% decline from 2022.
  • MACROGENICS INC annual Share-based Payment Arrangement, Expense for 2022 was $20,438,000, a 12% decline from 2021.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

MACROGENICS INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $22,889,000 $3,548,000 -$2,422,000 -41% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $25,311,000 $3,690,000 -$2,961,000 -45% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $28,272,000 $4,386,000 -$1,167,000 -21% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $29,439,000 $11,265,000 +$6,906,000 +158% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $22,533,000 $5,970,000 +$1,180,000 +25% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $21,353,000 $6,651,000 +$2,260,000 +51% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 $19,093,000 $5,553,000 +$720,000 +15% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $18,373,000 $4,359,000 -$382,000 -8.1% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $18,755,000 $4,790,000 -$333,000 -6.5% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024 2024 Q3
Q2 2023 $19,088,000 $4,391,000 -$909,000 -17% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024 2024 Q2
Q1 2023 $19,997,000 $4,833,000 -$441,000 -8.4% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $20,438,000 $4,741,000 -$671,000 -12% 01 Oct 2022 31 Dec 2022 10-K 20 Mar 2025 2024 FY
Q3 2022 $21,109,000 $5,123,000 -$1,235,000 -19% 01 Jul 2022 30 Sep 2022 10-Q 06 Nov 2023 2023 Q3
Q2 2022 $22,344,000 $5,300,000 -$770,000 -13% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023 2023 Q2
Q1 2022 $23,114,000 $5,274,000 -$12,000 -0.23% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $23,126,000 $5,412,000 +$154,000 +2.9% 01 Oct 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
Q3 2021 $22,972,000 $6,358,000 +$526,000 +9% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022 2022 Q3
Q2 2021 $22,446,000 $6,070,000 +$975,000 +19% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $21,471,000 $5,286,000 +$795,000 +18% 01 Jan 2021 31 Mar 2021 10-Q 03 May 2022 2022 Q1
Q4 2020 $20,676,000 $5,258,000 -$232,000 -4.2% 01 Oct 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
Q3 2020 $20,908,000 $5,832,000 +$434,000 +8% 01 Jul 2020 30 Sep 2020 10-Q 02 Nov 2021 2021 Q3
Q2 2020 $20,474,000 $5,095,000 +$211,000 +4.3% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 $20,263,000 $4,491,000 +$692,000 +18% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q4 2019 $19,571,000 $5,490,000 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $5,398,000 +$825,000 +18% 01 Jul 2019 30 Sep 2019 10-Q 04 Nov 2020 2020 Q3
Q2 2019 $4,884,000 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $3,799,000 01 Jan 2019 31 Mar 2019 10-Q 05 May 2020 2020 Q1
Q3 2018 $4,573,000 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019 2019 Q3
Q3 2013 $135,936 -$73,663 -35% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2013 2013 Q3
Q3 2012 $209,599 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013 2013 Q3

MACROGENICS INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $29,439,000 +$11,066,000 +60% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $18,373,000 -$2,065,000 -10% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $20,438,000 -$2,688,000 -12% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2025 2024 FY
2021 $23,126,000 +$2,450,000 +12% 01 Jan 2021 31 Dec 2021 10-K 07 Mar 2024 2023 FY
2020 $20,676,000 +$1,105,000 +5.6% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2023 2022 FY
2019 $19,571,000 +$3,051,000 +18% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $16,520,000 +$1,776,000 +12% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $14,744,000 +$2,579,000 +21% 01 Jan 2017 31 Dec 2017 10-K 25 Feb 2020 2019 FY
2016 $12,165,000 +$4,318,000 +55% 01 Jan 2016 31 Dec 2016 10-K 26 Feb 2019 2018 FY
2015 $7,847,000 +$4,603,000 +142% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $3,244,000 +$2,382,000 +276% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017 2016 FY
2013 $862,000 +$23,605 +2.8% 01 Jan 2013 31 Dec 2013 10-K 29 Feb 2016 2015 FY
2012 $838,395 -$1,509,044 -64% 01 Jan 2012 31 Dec 2012 10-K 20 Mar 2014 2013 FY
2011 $2,347,439 01 Jan 2011 31 Dec 2011 10-K 20 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.